Viewing Study NCT00390156


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-02-21 @ 12:42 AM
Study NCT ID: NCT00390156
Status: COMPLETED
Last Update Posted: 2020-07-28
First Post: 2006-10-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors
Sponsor:
Organization: